Perceptive Advisors LLC Celldex Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $6.35 Million - $9.04 Million	-229,807 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $5.84 Million - $9.22 Million	-163,806 Reduced 41.62%	229,807 $8.88 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $10.1 Million - $19.5 Million	-349,086 Reduced 47.0%	393,613 $21.3 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $15.4 Million - $26.3 Million	742,699 New	742,699 $24.8 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $745,767 - $1.13 Million	-49,751 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $480,097 - $755,717	49,751 New	49,751 $738,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.1B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.